0001437749-24-003018.txt : 20240202 0001437749-24-003018.hdr.sgml : 20240202 20240202191224 ACCESSION NUMBER: 0001437749-24-003018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Jason Drew CENTRAL INDEX KEY: 0001821479 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 24593469 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 400 ALEXANDER PARK DRIVE CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0508 4 2024-01-31 0001668243 UroGen Pharma Ltd. URGN 0001821479 Smith Jason Drew 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 General Counsel 0 Ordinary Shares 2024-01-31 4 M 0 834 A 19241 D Ordinary Shares 2024-01-31 4 S 0 417 15.74 D 18824 D Ordinary Shares 2024-01-31 4 M 0 2500 A 21324 D Ordinary Shares 2024-01-31 4 S 0 1248 15.74 D 20076 D Ordinary Shares 2024-01-31 4 M 0 6666 A 26742 D Ordinary Shares 2024-01-31 4 S 0 3328 15.74 D 23414 D Restricted Stock Units 2024-01-31 4 M 0 834 0 D Ordinary Shares 834 0 D Restricted Stock Units 2024-01-31 4 M 0 2500 0 D Ordinary Shares 2500 2500 D Restricted Stock Units 2024-01-31 4 M 0 6666 0 D Ordinary Shares 6666 13334 D Restricted Stock Units 2024-01-31 4 A 0 16500 0 A Ordinary Shares 16500 16500 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024. 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027. /s/ Jason D. Smith, Attorney-in-Fact 2024-02-02